Hesperos, LLC:1280468 [19-005001]
Ended Purchase Order Awarded Last action
- Contract number
- 75N95019P00551
- Awardee
-
Hesperos, Inc. UEI R1LSLA5YJMJ9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $100,000
Award facts
- Opportunity
-
- Development and Characterization of an NGLY1 Deficiency Disorder Human-on-a-Chip Model Pre-Solicitation · 75N95019Q00284 · Posted Aug 1, 2019
- Development and Characterization of an NGLY1 Deficiency Disorder Human-on-a-Chip Model Solicitation · Posted Aug 8, 2019
- Contract value 100% obligated
- $100,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Orlando, FL 32826, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $100,000 |
About this award
This federal contract was awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Hesperos, Inc., a for-profit organization located in Orlando, Florida. The contract is a $100,000 firm-fixed-price purchase order for Hesperos to establish in vitro phenotypic models of the NGLY1 deficiency disorder using its human-on-a-chip screening platform. This work will characterize the morphology and physiology of diseased and wild-type induced pluripotent stem cell (iPSC)-derived motor neurons, as well as test the lines for neuromuscular junction formation and physiology. The contract is not set aside for any small business designation. Hesperos has previously received grants from NIH agencies, including the National Institute on Aging and the National Institute of Environmental Health Sciences, to further develop its microphysiological systems for drug discovery and development.
Quick answers
Who was awarded contract 75N95019P00551?
75N95019P00551 was awarded to Hesperos, Inc. by National Institute on Drug Abuse (National Institutes of Health) on August 19, 2019.
How much is contract 75N95019P00551 worth?
The government has obligated $100,000 on 75N95019P00551.
Was contract 75N95019P00551 competed?
The extent of competition for 75N95019P00551 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award